↓ Skip to main content

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
86 Mendeley